Register entry

Verastem Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
1
Live patents
7
Exclusivities
1
Countries
0
Exclusivity

Patents and exclusivities

7
PatentProductCoversExpiry
7897792AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)avutometinib potassium; defactinib hydrochloridesubstance, productFeb 2027
8247411AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)avutometinib potassium; defactinib hydrochloridesubstance, productApr 2028
7928109AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)avutometinib potassium; defactinib hydrochloridesubstance, productAug 2029
11400090AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)avutometinib potassium; defactinib hydrochlorideuseOct 2038
11517573AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)avutometinib potassium; defactinib hydrochlorideuseSept 2040
11873296AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)avutometinib potassium; defactinib hydrochlorideproductDec 2042
12509450AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)avutometinib potassium; defactinib hydrochlorideproductDec 2042
ProductExclusivityUntil
AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)AVUTOMETINIB POTASSIUM; DEFACTINIB HYDROCHLORIDEODE-525 Orphan drugMay 2032
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
AVMAPKI FAKZYNJA CO-PACKavutometinib potassium and defactinib hydrochloridekit71779-623NDA
Enquiry

Common questions

Is Verastem Inc. FDA approved?
Verastem Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Verastem Inc. make?
1 product is listed under Verastem Inc. in the openFDA NDC Directory, most often as kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.